Merck’s CRISPRi whole-genome Libraries and Pools Pave the Way for Breakthroughs in Identifying Gene Pathways – PharmiWeb.com

Mercks CRISPRi whole-genome Libraries and Pools Pave the Way for Breakthroughs in Identifying Gene Pathways

Merck, a leading science and technology company, has launched its CRISPR inhibition (CRISPRi) whole-genome libraries and pools to complement its industry-leading suite of genome-editing products and technologies. CRISPRi is a useful tool for screening an entire genome, smaller gene family or individual targets. The CRISPRi libraries are fully customizable, providing the same flexibility as the entire family of Merck screening products.

Instead of imprecise DNA repair to knock out a gene, CRISPRi modulates gene expression, allowing for robust loss-of-function studies, even in essential genes, with fewer off-target effects. CRISPRi provides unique insights into the underlying biology often missed when only using gene knock out or overexpression studies. Using CRISPRi as a discovery tool, researchers can make scientific breakthroughs in idenfying new disease pathways or drug targets.

The whole CRISPRi libraries and pools were created by the University of California, San Francisco, USA, and further enhanced by the Life Science business of Merck, resulting in superior algorithm design and improved scaffolding that has been proven to increase gene knock down, even in difficult-to-repress targets. The CRISPRi offerings feature:

Mercks comprehensive gene modulation offering also includes CRISPR activation (CRISPRa) whole-genome libraries and pools, often used in conjunction with CRISPRi.

The Life Science business provides a full suite of screening tools for genome-editing applications including CRISPR knock out, RNAi knock down and open reading frame gain-of-function studies. Genome-editing and gene modulation technologies complement each other and used together, they can fully elucidate gene pathways and identify drug targets.

With 17 years of experience in the genome-editing field, the Life Science business of Merck is a global leader in developing innovative CRISPR tools, products and services to support every step of genome engineering-facilitated research, from basic research to therapeutic delivery.

Learn more about Mercks new CRISPRi whole-genome libraries and pools.

See the rest here:
Merck's CRISPRi whole-genome Libraries and Pools Pave the Way for Breakthroughs in Identifying Gene Pathways - PharmiWeb.com